On the other hand, another E2 metabolite, 2-methoxyestradiol (2-ME), is reported to possess antiproliferative properties in both estrogen receptor positive (ER+) and negative (ER-) BC cells [14] and to enhance the therapeutic effects of taxanes [11]. This evidence concerns the gene ESR1 and breast cancer.